India's largest drugmaker by revenue Sun Pharmaceutical is aiming to launch its experimental anti-obesity and type 2 diabetes ...

The young businesswoman has been with her current company for over a decade.

India's largest drugmaker by revenue Sun Pharmaceutical is aiming to launch its experimental anti-obesity and type 2 diabetes ...

But Dilip Shanghvi, 67, is no ordinary man. The child poring through medicine labels decided one fine day to make medicines himself, and became successful, way beyond probably what he himself ...

In 2015, the chairman of Sun Pharma Dilip Shanghvi had briefly dethroned Mukesh Ambani to become the country’s richest man. His response to that was, “I am not comfortable.” Though he doesn ...

Tariffs should not influence decisions at Indian drug companies, Cipla's top executive said on Friday, as the industry braces ...

Sharing details of Sun Pharma's mergers and acquisitions (M&As) and strategic partnerships, Dilip Shanghvi said, "We are currently in the process of integrating Concert Pharmaceuticals that we ...

Prime Minister Pham Minh Chinh has directed relevant ministries to consider exempting visas for tourists from some countries ...

A global collaboration towards a secure supply-chain or a differentiated manufacturing model are just some of the options ...

Indian pharmaceutical industry leaders indicate that proposed US tariffs on pharmaceutical exports may lead to increased drug ...

The 2-day Indian Pharma Alliance Conference concluded on Friday and speaking at the conference, Founder and MD of Sun Pharma, Dilip Shanghvi as well as Pankaj Patel of Zydus Cadila say that ...

India, often dubbed the "pharmacy of the world", is among the top exporters to the U.S., especially for cheaper versions of ...